Type 2 diabetes mellitus and thyrotoxicosis presenting concurrently

International Journal of Clinical Practice

Volumn 56, Issue 9, 2002, Pages 701-703

  Shah, D ^a   Turnbull, C J ^a  

^a ARROWE PARK HOSPITAL   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

CARBIMAZOLE; GLUCOSE; IODINE 131; LIOTHYRONINE; THYROTROPIN; THYROXINE;

AGED; ANOREXIA; ARTICLE; CASE REPORT; COMORBIDITY; CONTROLLED STUDY; DIABETIC DIET; DIAGNOSTIC TEST; FATIGUE; FEMALE; GLUCOSE BLOOD LEVEL; HUMAN; HYPERTENSION; LETHARGY; LIMB PAIN; MICTURITION DISORDER; MYOPATHY; NEUROLOGIC EXAMINATION; NON INSULIN DEPENDENT DIABETES MELLITUS; ORAL GLUCOSE TOLERANCE TEST; PRIORITY JOURNAL; SYMPTOMATOLOGY; TACHYCARDIA; THYROID FUNCTION TEST; THYROTOXICOSIS;

AGED; DIABETES MELLITUS, TYPE 2; FEMALE; GLUCOSE INTOLERANCE; HUMANS; THYROTOXICOSIS;

EID: 0036856351     PISSN: 13685031     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (17)

1. Perros P, McCrimmon RJ, Shaw G, Filer BM. Frequency of thyroid dysfunction in diabetic patients: value of annual screening. Diabet Med 1995; 12(7): 622-627.
2. Mouradian M, Ahourizk N. Diabetes mellitus and thyroid disease. Diabetes Care 1983; 6(5): 512-520.
3. Sugrue DD, McEvoy M, Drury MI. Thyroid disease in diabetics. Postgrad Med J 1982; 58: 680-684.
4. Suzuki S. Diabetes secondary to endocrinopathies. Nippon-Rinsho 1996; 54(10): 2709-2714.
5. Drury MI, Timoney FJ. Diabetes mellitus and concurrent autoimmune disease. Ir J Med Sci 1974; 43(1): 42-53.
6. Gupta A, Habubi N, Thomas P. Abnormalities of thyroid hormonal function tests in hospitalised elderly patients: a prospective study. Int J Clin Pract 2001; 55(9): 582-583.
7. Gray RS, Irvine WJ, Toft AD et al. Unrecognised thyroid failure in diabetes mellitus. J Clin Lab Immunol 1979; 2: 221-224.
8. Feely J, Isles TE. Screening for thyroid dysfunction in diabetics. BMJ 1979; 1: 1678.
9. King H, Aubert RE, Herman WH. Global burden of diabetes, 1995-2025: prevalence, numerical estimates, and projections. Diabetes Care 1998; 21(9): 1414-1431.
10. Fact sheet 1. Diabetes in the United Kingdom. Diabetes Update, Autumn 1995; 8.
11. Yudkin JS, Forrest RD, Jackson CA et al. The prevalence of diabetes and impaired glucose tolerance in a British population. Diabetes Care 1993; 16(11): 1530.
12. McCulloch AJ, Steele NR, Kendall-Taylor P et al. Enhanced gluconeogenic capacity from glycerol in hyperthyroid man: evidence in favour of a beta-adrenergic mechanism. Clin Endocrinol 1984; 21(4): 399-407.
13. McCulloch AJ, Johnston DG, Baylis PH et al. Evidence that thyroid hormones regulate gluconeogenesis from glycerol in men. Clin Endocrinol 1983; 19(1): 67-76.
14. Celani MF, Bonati ME, Stucci N. Prevalence of abnormal thyrotropin concentrations measured by a sensitive assay in patients with type 2 diabetes mellitus. Diabetes Res 1994; 27(1): 15-25.
15. Wu TJ, Huang SM, Taylor RL, Kao PC. Abnormal proinsulin levels in thyroid dysfunction measured by a sensitive proinsulin immunochemiluminoassay. Ann Clin Lab Sci 1998; 28(2): 82-87.
16. Tosi F, Moghetti P, Castello R et al. Early changes in plasma glucagon and growth hormone response to oral glucose in experimental hyperthyroidism. Metabolism 1996; 45(8): 1029-1033.
17. Foster DW. Endocrinology and metabolic diseases. In: Harrison's principles of internal medicine, 14th edn, pt 13, sec 1, chap 334, 1998.